Theron Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.theronpharma.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
- First Posted Date
- 2015-03-06
- Last Posted Date
- 2017-05-09
- Lead Sponsor
- Theron Pharmaceuticals, Inc.
- Target Recruit Count
- 59
- Registration Number
- NCT02382510
- Locations
- 🇺🇸
WCCT Global, Costa Mesa, California, United States
🇺🇸Allied Clinical Research, Reno, Nevada, United States
🇺🇸Dr. Winder & Associates/Toledo Center for Clinical Research, Sylvania, Ohio, United States
Single Ascending Dose Study of TRN-157 in Healthy Subjects
Phase 1
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-05-08
- Last Posted Date
- 2014-10-31
- Lead Sponsor
- Theron Pharmaceuticals, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02133339
News
No news found